Antimicrobial Stewardship in Neonates: Challenges and Opportunities

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pharmacology

Background:

• Neonatal infections cause significant illness and death.
• Antibiotics are crucial but can harm the neonatal microbiome and lead to resistance.
• Early decisions on empiric antibiotic use are critical for newborns.

Purpose of the Study:

• To review current guidelines for antibiotic use in neonatal infections.
• To discuss the role of risk stratification tools in guiding empiric antibiotic therapy.
• To emphasize antimicrobial stewardship strategies in the neonatal intensive care unit.

Main Methods:

• Literature review of antibiotic guidelines for neonatal sepsis.
• Analysis of pharmacokinetic data for appropriate dosing.
• Discussion of evidence supporting risk stratification tools versus traditional decision trees.

Main Results:

• Ampicillin and aminoglycosides are recommended first-line agents for early-onset sepsis.
• Third-generation cephalosporins are reserved for suspected Gram-negative meningitis.
• Antistaphylococcal penicillin and gentamicin are suggested for late-onset sepsis; vancomycin for resistant organisms.

Conclusions:

• Optimizing antibiotic selection and duration based on clinical evidence and cultures is essential.
• Antimicrobial stewardship programs involving multidisciplinary teams can improve antibiotic utilization.
• A collaborative approach is needed to reduce antibiotic resistance and improve patient outcomes.